Published in
Springer Verlag, Clinical Rheumatology, 4(37), p. 1123-1127
DOI: 10.1007/s10067-017-3867-3
Links
Tools
Anti-fibrotic nintedanib—a new opportunity for systemic sclerosis patients?
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 